Samuel Nardin, Ejaz Resham, Silver Josh, Ezzat Shereen, Cusimano Robert J, Kim Raymond H
MD/PhD Program, Faculty of Medicine, University of Toronto, Toronto, ON.
Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON.
J Surg Oncol. 2018 Feb;117(2):160-162. doi: 10.1002/jso.24818. Epub 2017 Sep 10.
Surgical management is the mainstay of therapy for primary cardiac tumors, yet due to the rarity of these malignancies, their management and workup remains a challenge. Here, we report a unique case of a patient with a primary left ventricular cardiac paraganglioma (PGL) and describe the role of a medical genetics assessment leading to the identification of a rare variant in the SDHB gene to be the causative etiology of this cardiac tumor. Due to decreasing costs and accessibility of molecular genetic analysis, genetic testing may become an emerging diagnostic adjunct in cases of cardiac tumors.
手术治疗是原发性心脏肿瘤治疗的主要手段,但由于这些恶性肿瘤罕见,其管理和检查仍是一项挑战。在此,我们报告一例原发性左心室心脏副神经节瘤(PGL)患者的独特病例,并描述医学遗传学评估的作用,该评估导致鉴定出SDHB基因中的一种罕见变异是这种心脏肿瘤的病因。由于分子遗传学分析的成本降低和可及性提高,基因检测可能成为心脏肿瘤病例中一种新兴的诊断辅助手段。